Summary and comparison of myeloid growth factor guidelines in patients receiving cancer chemotherapy
- PMID: 17335690
- DOI: 10.6004/jnccn.2007.0021
Summary and comparison of myeloid growth factor guidelines in patients receiving cancer chemotherapy
Abstract
Three different practice guidelines for the myeloid growth factors were recently published by major professional organizations. A comprehensive review and comparison of the guidelines using a priori structured content criteria and a previously validated quality appraisal tool are reported. The final recommendations from these guidelines are consistent for primary prophylaxis with the colony-stimulating factors (CSFs) when the risk of febrile neutropenia is in the range of 20% or greater. All 3 guidelines also recommend prophylactic use of myeloid growth factors in patients with important factors increasing individual risk of neutropenic complications. The recommendation that patients receiving regimens associated with lower risk should have CSF use guided by individual risk assessment is also consistent. Critical quality appraisal indicates that the scope, purpose, stakeholder involvement, and applicability of these guidelines differ little. The American Society of Clinical Oncology and European Organization for Research and Treatment of Cancer guidelines place more emphasis on comprehensive literature reviews, and the National Comprehensive Cancer Network guidelines are more current based on systematic annual updates. Presentation clarity also favors National Comprehensive Cancer Network guidelines, with recommendations generally presented as both text and algorithmic diagram.
Comment in
-
Myeloid Growth Factor Guidelines: moving toward a societal perspective.J Natl Compr Canc Netw. 2007 Feb;5(2):117. doi: 10.6004/jnccn.2007.0013. J Natl Compr Canc Netw. 2007. PMID: 17366693 No abstract available.
Similar articles
-
Summary and comparison of myeloid growth factor guidelines in patients receiving cancer chemotherapy.Cancer Treat Res. 2011;157:145-65. doi: 10.1007/978-1-4419-7073-2_9. Cancer Treat Res. 2011. PMID: 21052955 Review.
-
Granulocyte colony-stimulating factors: finding the right indication.Curr Opin Oncol. 2007 Jul;19(4):299-307. doi: 10.1097/CCO.0b013e3281a3c0ba. Curr Opin Oncol. 2007. PMID: 17545791 Review.
-
Colony-stimulating factors for the management of neutropenia in cancer patients.Drugs. 2002;62 Suppl 1:1-15. doi: 10.2165/00003495-200262001-00001. Drugs. 2002. PMID: 12479591 Review.
-
Guidelines of the National Comprehensive Cancer Network on the use of myeloid growth factors with cancer chemotherapy: a review of the evidence.J Natl Compr Canc Netw. 2005 Jul;3(4):557-71. doi: 10.6004/jnccn.2005.0031. J Natl Compr Canc Netw. 2005. PMID: 16038646 Review.
-
A comparison of international guidelines for the prevention of chemotherapy-induced neutropenia.Curr Opin Hematol. 2011 Jan;18(1):1-10. doi: 10.1097/MOH.0b013e328340dc51. Curr Opin Hematol. 2011. PMID: 21042215 Review.
Cited by
-
How we treat febrile neutropenia in patients receiving cancer chemotherapy.J Oncol Pract. 2010 May;6(3):149-52. doi: 10.1200/JOP.091092. J Oncol Pract. 2010. PMID: 20808559 Free PMC article.
-
Treatment options in Invasive Aspergillosis.Curr Treat Options Infect Dis. 2014 Sep;6(3):309-325. doi: 10.1007/s40506-014-0016-2. Curr Treat Options Infect Dis. 2014. PMID: 25328449 Free PMC article. No abstract available.
-
Pharmacoeconomics of the myeloid growth factors: a critical and systematic review.Pharmacoeconomics. 2012 Jun 1;30(6):497-511. doi: 10.2165/11590130-000000000-00000. Pharmacoeconomics. 2012. PMID: 22540394 Review.
-
Does chemotherapy-induced neutropaenia result in a postponement of adjuvant or neoadjuvant regimens in breast cancer patients? Results of a retrospective analysis.Br J Cancer. 2007 Dec 17;97(12):1642-7. doi: 10.1038/sj.bjc.6604094. Epub 2007 Nov 13. Br J Cancer. 2007. PMID: 18000502 Free PMC article.
-
Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapy.Cancer. 2011 May 1;117(9):1917-27. doi: 10.1002/cncr.25691. Epub 2010 Nov 29. Cancer. 2011. PMID: 21509769 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources